CAS NO: | 1072443-89-0 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | SK1-I (BML-258), an analog of sphingosine, is an isozyme-specific competitiveSPHK1inhibitor with aKivalue of 10 μM[1]. SK1-I shows no activity atSPHK1PKCα,PKCδ,PKA,AKT1,ERK1,EGFR,CDK2, IKKβ or CamK2β. SK1-I enhancesautophagyand has antitumor activity[2]. | ||||||||||||||||
IC50& Target | Ki: 10 μM (SPHK1)[1] | ||||||||||||||||
体外研究 (In Vitro) | SK1-I (0-10 μM; 24 hours) attenuates cancer cell growth and survival in a TP53-dependent manner in HCT116 cells and HCT116 cells bearingTP53null cancer[2]. Cell Viability Assay[2]
Western Blot Analysis[2]
| ||||||||||||||||
体内研究 (In Vivo) | Pre-treatment with SK1-I (BML-258; intraperitoneal (i.p.) injection; once; 24 hours prior to baseline mean arterial blood pressure (MAP) measurement; 75 mg/kg) before anandamide (i.v. injection; two doses; 1 and 10 mg/kg) significantly decreases the hypotensive response[3].
| ||||||||||||||||
分子量 | 277.40 | ||||||||||||||||
Formula | C17H27NO2 | ||||||||||||||||
CAS 号 | 1072443-89-0 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |